Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 120709-09-3
2. (6r,7r)-7-amino-8-oxo-3-(1-propenyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
3. 107937-01-9
4. 7-apra
5. 4ze15v22rd
6. (6r,7r)-7-amino-8-oxo-3-((1e)-prop-1-enyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid
7. (6r,7r)-7-amino-8-oxo-3-[(e)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
8. 7-amino-8-oxo-3-((1e)-prop-1-enyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, (6r,7r)-
9. De(2-amino-2-(4-hydroxyphenyl)acetyl)cefprozil, (e)-
10. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-amino-8-oxo-3-(1e)-1-propen-1-yl-, (6r,7r)-
11. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-amino-8-oxo-3-(1e)-1-propenyl-, (6r,7r)-
12. (6r,7r)-7-amino-8-oxo-3-[(1e)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
13. Cefprozil Impurity F [ep]
14. Unii-4ze15v22rd
15. 7 Apra
16. Cefprozil Monohydrate Impurity F [ep]
17. Cefprozil Ep Impurity D
18. Cefprozil Ep Impurity F
19. (6r,7r)-7-amino-8-oxo-3-(1-propenyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carbo
20. Dtxsid20148332
21. Act05294
22. Amy27770
23. Bcp10063
24. Mfcd08458212
25. Zinc21992405
26. Akos015964988
27. Akos025149355
28. Ac-1879
29. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-amino-8-oxo-3-(1-propenyl)-, (6r-(3(e),6alpha,7beta))-
30. As-15055
31. Cefprozil Impurity F [ep Impurity]
32. H11004
33. 709a093
34. A892112
35. Cefprozil Monohydrate Impurity F [ep Impurity]
36. Q27260710
37. Cefprozil Related Compound D (e)-isomer [usp Impurity]
38. (6r,7r)-7-amino-8-oxo-3-(1-propenyl)-5-thia-1-azabicyclo [4. 2.0]oct-2--ene-2- Carboxylic Acid
39. (6r,7r)-7-amino-8-oxo-3-(1-propenyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid; Cefprozil Intermediate; Cefprozil Main-ring
40. (6r,7r)-7-amino-8-oxo-3-(prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid
41. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-amino-8-oxo-3-(1-propenyl)-, (6r-(3(e),6.alpha.,7.beta.))-
42. Cefprozil Usp Related Compound D; (6r,7r)-7-amino-8-oxo-3-[(1z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
| Molecular Weight | 240.28 g/mol |
|---|---|
| Molecular Formula | C10H12N2O3S |
| XLogP3 | -2.5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 2 |
| Exact Mass | 240.05686342 g/mol |
| Monoisotopic Mass | 240.05686342 g/mol |
| Topological Polar Surface Area | 109 Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 416 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Molport-005-940-664 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Molport-005-940-664, including repackagers and relabelers. The FDA regulates Molport-005-940-664 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Molport-005-940-664 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Molport-005-940-664 supplier is an individual or a company that provides Molport-005-940-664 active pharmaceutical ingredient (API) or Molport-005-940-664 finished formulations upon request. The Molport-005-940-664 suppliers may include Molport-005-940-664 API manufacturers, exporters, distributors and traders.
Molport-005-940-664 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Molport-005-940-664 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Molport-005-940-664 GMP manufacturer or Molport-005-940-664 GMP API supplier for your needs.
A Molport-005-940-664 CoA (Certificate of Analysis) is a formal document that attests to Molport-005-940-664's compliance with Molport-005-940-664 specifications and serves as a tool for batch-level quality control.
Molport-005-940-664 CoA mostly includes findings from lab analyses of a specific batch. For each Molport-005-940-664 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Molport-005-940-664 may be tested according to a variety of international standards, such as European Pharmacopoeia (Molport-005-940-664 EP), Molport-005-940-664 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Molport-005-940-664 USP).
LOOKING FOR A SUPPLIER?
